Aristotle Capital Boston, LLC Coherus Bio Sciences, Inc. Transaction History

Aristotle Capital Boston, LLC

$2.93 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $138,140 - $201,301	36,936 Added 1.6%	2,342,977 $8.76 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $196,848 - $431,093	51,939 Added 2.3%	2,306,041 $9.85 Million
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $986,739 - $1.76 Million	167,528 Added 8.03%	2,254,102 $15.4 Million
Q4 2022 Feb 14, 2023	SELL	$5.69 - $10.07 $311,846 - $551,896	-54,806 Reduced 2.56%	2,086,574 $16.5 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $1.3 Million - $2.51 Million	-180,788 Reduced 7.79%	2,141,380 $20.6 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $759,256 - $1.71 Million	129,566 Added 5.91%	2,322,168 $16.8 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $1.15 Million - $1.73 Million	105,415 Added 5.05%	2,192,602 $28.3 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $1.08 Million - $1.29 Million	-68,034 Reduced 3.16%	2,087,187 $33.3 Million
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $2.09 Million - $2.93 Million	164,778 Added 8.28%	2,155,221 $34.6 Million
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $1.44 Million - $1.71 Million	-111,244 Reduced 5.29%	1,990,443 $27.5 Million
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $4.59 Million - $6.82 Million	318,607 Added 17.87%	2,101,687 $30.7 Million
Q4 2020 Feb 22, 2021	BUY	$16.56 - $18.94 $179,344 - $205,120	10,830 Added 0.61%	1,783,080 $31 Million
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $13.8 Million - $15.8 Million	834,976 Added 89.09%	1,772,250 $30.8 Million
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $5.61 Million - $6.41 Million	322,242 Added 52.39%	937,274 $17.2 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $8.87 Million - $11.8 Million	615,032 New	615,032 $11 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Account